[Clinical orientation of post-marketing Chinese patent drugs: an evidence-based practice]

Zhong Xi Yi Jie He Xue Bao. 2008 Sep;6(9):887-90. doi: 10.3736/jcim20080902.
[Article in Chinese]

Abstract

Unclear clinical orientation in practice has become one of the common problems with the effective application of famous and excellent Chinese herbal drugs, consequently restricting their development. The authors suggest that there are three aspects to be considered in dealing with this problem. Clinical evaluation and orientation of the famous and excellent Chinese herbal drugs is an important task, and it is also a requirement for the internationalization of traditional Chinese medicine. Literature evaluation-pharmacology research-clinical expertise analysis method will establish a theoretical basis and method for post-marketing development of famous and excellent Chinese patent drugs.

Publication types

  • Editorial
  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Evaluation
  • Drug Therapy / standards
  • Drugs, Chinese Herbal / standards*
  • Drugs, Chinese Herbal / therapeutic use
  • Evidence-Based Medicine* / methods
  • Humans
  • Medicine, Chinese Traditional / standards*
  • Patents as Topic*
  • Product Surveillance, Postmarketing / standards*

Substances

  • Drugs, Chinese Herbal